Jeff Davis Examines Potential Legal Challenges to New 340B Medicare Payment Rule
Bass BerryTopic alignment 92
Cut through the noise, find the signal: Intelligence for serious healthcare leaders
340B drug pricing program, contract pharmacy, rebate model, manufacturer restrictions, 340B litigation
Bass BerryTopic alignment 92
MedTech DiveTopic alignment 90
Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.
Also covered by BioPharma Dive, Healthcare Dive
Turquoise Health (blog and reports)Topic alignment 92
HFMATopic alignment 86
In the 2027 Medicare final rule for hospital outpatient departments, CMS slightly mitigated several issues that providers had cited regarding the proposed version of the rule. Those steps have not assuaged stakeholder concerns about the rule’s impact on…
America's Essential HospitalsTopic alignment 85
MLN Connects NewsletterTopic alignment 88
340B ReportTopic alignment 90
CMS on Wednesday finalized a rule requiring 340B covered entities to submit Medicare Part D claims for all 340B drugs [...]
340B ReportTopic alignment 95
CMS late Wednesday finalized a rule to slash Medicare Part B payments to certain 340B hospitals by 32%, drawing immediate [...]
Becker's Hospital ReviewTopic alignment 95
America's Essential HospitalsTopic alignment 88
America's Essential HospitalsTopic alignment 95
Becker's Hospital ReviewTopic alignment 92
STAT NewsTopic alignment 92
Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.
Healthcare FinanceTopic alignment 92
340B ReportTopic alignment 92
The Missouri Attorney General’s office told a major drugmaker on Monday to “cease and desist” its 340B in-house pharmacy claims [...]
340B ReportTopic alignment 95
RICHMOND, Va.—Federal appellate judges on Tuesday expressed sharply diverging views on whether Maryland and West Virginia can regulate 340B contract [...]
Health LeadersTopic alignment 92
340B ReportTopic alignment 92
A Michigan Republican on Thursday quietly introduced a long-awaited, bipartisan U.S. House legislation that would exempt a range of covered [...]
AHATopic alignment 92
Frier LevittTopic alignment 85
Oscar Health (“Oscar”) has recently suspended claims adjudication for a number of pharmacies in Miami-Dade County and the surrounding South Florida area. The suspended pharmacies share two characteristics. Each dispenses pre-exposure prophylaxis (“PrEP”) for…
340B ReportTopic alignment 92
A full Richmond, Virginia, federal appeals court is holding high-stakes oral arguments today as it reconsiders two earlier decisions against [...]
340B ReportTopic alignment 88
Germany-based Fresenius Kabi recently became the 45th drugmaker to announce 340B contract pharmacy restrictions and the 17th to announce in-house [...]
340B ReportTopic alignment 92
Five major Massachusetts hospitals on Tuesday sued Eli Lilly for allegedly cutting off their access to 340B pricing after they [...]
340B ReportTopic alignment 88
As 340B litigation heats up in the states following the enactment of new contract pharmacy access and claims data restriction [...]
340B ReportTopic alignment 92
A bipartisan group of 14 U.S House members unveiled a bill Thursday that would end the Trump administration’s 340B rebate [...]